Christopher Brett Primiano, SVP, Corporate Development, General COUNSEL&SEC at Karyopharm Therapeutics Inc. (KPTI), sold 4,342 shares at $8.19 ($36K) on 2016-11-09, disclosed to the SEC on 2016-11-14.
Open-market sale of $36k KPTI by SVP, Corporate Development, General COUNSEL&SEC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |